Shows
Transplant ID CastCryptococcal MeningitisJoin me for a case based review of Cryptococcal meningitis in non-HIV patients.2025-02-1230 minTransplant ID CastTopic Review: PneumocystisJoin me in this episode for a presentation on Pneumocystis jirovecii.2024-10-1627 minTransplant ID CastTopic review: Invasive candidiasisTune in to this episode of the Transplant ID podcast for a case based learning module on the topic of invasive candidiasis and its therapy.2024-09-2529 minTransplant ID CastJulie Steinbrink InterviewToday I am joined by Dr. Julie Steinbrink, assistant professor of medicine at the Division of Infectious Disease at Duke University School of Medicine. In this episode, we are discussing fungal diagnostics, transcriptional signatures, and also HCV in transplant. 2024-06-0547 min
Daf Yomi for Women - HadranBava Metzia 11 - Rosh Chodesh Adar 2 - March 10, 30 Adar 1Today's daf is sponsored by Emma and Richard Rinberg in honor of the engagement of their son Joseph to Shachar, daughter of Ayelet and Amir Yefet of Shoham. After concluding that everyone agrees that if a husband puts a get in his wife's courtyard, she is divorced because her courtyard is considered an extension of her hand, the Gemara brings three explanations as to what Reish Lakish and Rabbi Yochanan disagree about regarding the acquiring of an item through the courtyard of a minor. If people are running after an animal with a broken leg who has...2024-03-1044 minTransplant ID CastInterview with Joseph Sassine from University of Oklahoma on RSV, CMV, Clinical Trial Design and Much MoreDrs. Joseph Sassine and Shmuel Shoham discuss clinical trials for respiratory viral infections in immunocompromised patients, CMV prevention options, and medical education in different places around the world.2024-01-2440 min
PeerView Oncology & Hematology CME/CNE/CPE Audio PodcastShmuel Shoham, MD - Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for...2024-01-131h 30
PeerView Internal Medicine CME/CNE/CPE Audio PodcastShmuel Shoham, MD - Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for...2024-01-131h 30
PeerView Internal Medicine CME/CNE/CPE Video PodcastShmuel Shoham, MD - Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for...2024-01-131h 30
PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastShmuel Shoham, MD - Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for...2024-01-131h 30
PeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastShmuel Shoham, MD - Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for...2024-01-131h 30
PeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastShmuel Shoham, MD - Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for...2024-01-131h 30
PeerView Oncology & Hematology CME/CNE/CPE Video PodcastShmuel Shoham, MD - Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for...2024-01-131h 30
PeerView Clinical Pharmacology CME/CNE/CPE VideoShmuel Shoham, MD - Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for...2024-01-131h 30
PeerView Infectious Diseases CME/CNE/CPE Audio PodcastShmuel Shoham, MD - Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for...2024-01-131h 30
PeerView Infectious Diseases CME/CNE/CPE Video PodcastShmuel Shoham, MD - Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/JXH865. CME credit will be available until December 31, 2024.Toward a Brighter Future for Preventing COVID-19 in Patients With Hematologic Malignancies: Leveraging the Power of Current Strategies and Next-Generation AgentsPenn State College of Medicine is accredited by the Accreditation Council for...2024-01-131h 30Transplant ID CastCAR-T cells and Infections and Logistics of Bacteriophages for Serious InfectionsIn this episode, I interview Dr. Jessica Little from Brigham and Women's Hospital and Dana Farber. We talk about CAR-T cells and infections and also about the logistics of using bacteriophages for tough to treat infections.2023-11-2244 minTransplant ID CastInterview with Nina Martinez and Ken Teasley on being a kidney donor and kidney recipient, patient advocacy, and HIVIn this episode, I am joined by Nina Martinez and Ken Teasley. They are sharing their experiences as a kidney donor and a kidney recipient. We are also discussing patient advocacy and HIV. 2023-09-271h 06Transplant ID CastInterview with Michael P AngaroneToday I am interviewing Michael P Angarone. We are discussing the topic of diarrheal illness in transplant patients.2023-09-1351 minTransplant ID CastTropical meets Transplant. Demystifying Chagas and transplantIn this episode, I am joined by Dr. Laila Woc-Coburn. We are discussing Chagas screening, diagnosis, and treatment in transplant patients.2023-08-3050 minTransplant ID CastValley Fever: Interview with George ThompsonIn this episode, I Interview George Thompson from UC Davis. Join us as we talk all about Coccidioidomycosis and more.2023-08-0247 minTransplant ID CastAll about EBV. Interview with Sankar SwaminathanIn this episode of the Transplant ID cast, I am interviewing Professor Sankar Swaminathan from University of Utah. We are covering various aspects of EBV and the future of ID.2023-07-0554 minPeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastShmuel Shoham, MD / Ghady Haidar, MD - What’s New, and What’s Next? Customizing COVID-19 Prevention Approaches in Transplant Patients to Increase Uptake, Access, and EfficacyGo online to PeerView.com/ERY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hundreds of thousands of organ transplant recipients living in the United States, who must take immunosuppressive medication, are at an increased risk of COVID-19 infection. Tixagevimab co-packaged with cilgavimab has lost its emergency use authorization as prevention for immunocompromised patients because of its lack of efficacy against newer variants. In the absence of prevention agents (other than vaccines) and because the prevention of COVID-19 is shifting to a more personalized, patient-specific approach, the complexity of clinical decision-making has...2023-07-0157 minPeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastShmuel Shoham, MD / Ghady Haidar, MD - What’s New, and What’s Next? Customizing COVID-19 Prevention Approaches in Transplant Patients to Increase Uptake, Access, and EfficacyGo online to PeerView.com/ERY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hundreds of thousands of organ transplant recipients living in the United States, who must take immunosuppressive medication, are at an increased risk of COVID-19 infection. Tixagevimab co-packaged with cilgavimab has lost its emergency use authorization as prevention for immunocompromised patients because of its lack of efficacy against newer variants. In the absence of prevention agents (other than vaccines) and because the prevention of COVID-19 is shifting to a more personalized, patient-specific approach, the complexity of clinical decision-making has...2023-07-0157 minPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastShmuel Shoham, MD / Ghady Haidar, MD - What’s New, and What’s Next? Customizing COVID-19 Prevention Approaches in Transplant Patients to Increase Uptake, Access, and EfficacyGo online to PeerView.com/ERY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hundreds of thousands of organ transplant recipients living in the United States, who must take immunosuppressive medication, are at an increased risk of COVID-19 infection. Tixagevimab co-packaged with cilgavimab has lost its emergency use authorization as prevention for immunocompromised patients because of its lack of efficacy against newer variants. In the absence of prevention agents (other than vaccines) and because the prevention of COVID-19 is shifting to a more personalized, patient-specific approach, the complexity of clinical decision-making has...2023-07-0157 minPeerView Internal Medicine CME/CNE/CPE Video PodcastShmuel Shoham, MD / Ghady Haidar, MD - What’s New, and What’s Next? Customizing COVID-19 Prevention Approaches in Transplant Patients to Increase Uptake, Access, and EfficacyGo online to PeerView.com/ERY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hundreds of thousands of organ transplant recipients living in the United States, who must take immunosuppressive medication, are at an increased risk of COVID-19 infection. Tixagevimab co-packaged with cilgavimab has lost its emergency use authorization as prevention for immunocompromised patients because of its lack of efficacy against newer variants. In the absence of prevention agents (other than vaccines) and because the prevention of COVID-19 is shifting to a more personalized, patient-specific approach, the complexity of clinical decision-making has...2023-07-0157 min
PeerView Immunology & Transplantation CME/CNE/CPE Video PodcastShmuel Shoham, MD / Ghady Haidar, MD - What’s New, and What’s Next? Customizing COVID-19 Prevention Approaches in Transplant Patients to Increase Uptake, Access, and EfficacyGo online to PeerView.com/ERY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hundreds of thousands of organ transplant recipients living in the United States, who must take immunosuppressive medication, are at an increased risk of COVID-19 infection. Tixagevimab co-packaged with cilgavimab has lost its emergency use authorization as prevention for immunocompromised patients because of its lack of efficacy against newer variants. In the absence of prevention agents (other than vaccines) and because the prevention of COVID-19 is shifting to a more personalized, patient-specific approach, the complexity of clinical decision-making has...2023-07-0157 min
PeerView Immunology & Transplantation CME/CNE/CPE Audio PodcastShmuel Shoham, MD / Ghady Haidar, MD - What’s New, and What’s Next? Customizing COVID-19 Prevention Approaches in Transplant Patients to Increase Uptake, Access, and EfficacyGo online to PeerView.com/ERY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hundreds of thousands of organ transplant recipients living in the United States, who must take immunosuppressive medication, are at an increased risk of COVID-19 infection. Tixagevimab co-packaged with cilgavimab has lost its emergency use authorization as prevention for immunocompromised patients because of its lack of efficacy against newer variants. In the absence of prevention agents (other than vaccines) and because the prevention of COVID-19 is shifting to a more personalized, patient-specific approach, the complexity of clinical decision-making has...2023-07-0157 minPeerView Internal Medicine CME/CNE/CPE Audio PodcastShmuel Shoham, MD / Ghady Haidar, MD - What’s New, and What’s Next? Customizing COVID-19 Prevention Approaches in Transplant Patients to Increase Uptake, Access, and EfficacyGo online to PeerView.com/ERY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hundreds of thousands of organ transplant recipients living in the United States, who must take immunosuppressive medication, are at an increased risk of COVID-19 infection. Tixagevimab co-packaged with cilgavimab has lost its emergency use authorization as prevention for immunocompromised patients because of its lack of efficacy against newer variants. In the absence of prevention agents (other than vaccines) and because the prevention of COVID-19 is shifting to a more personalized, patient-specific approach, the complexity of clinical decision-making has...2023-07-0157 minPeerView Clinical Pharmacology CME/CNE/CPE VideoShmuel Shoham, MD / Ghady Haidar, MD - What’s New, and What’s Next? Customizing COVID-19 Prevention Approaches in Transplant Patients to Increase Uptake, Access, and EfficacyGo online to PeerView.com/ERY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hundreds of thousands of organ transplant recipients living in the United States, who must take immunosuppressive medication, are at an increased risk of COVID-19 infection. Tixagevimab co-packaged with cilgavimab has lost its emergency use authorization as prevention for immunocompromised patients because of its lack of efficacy against newer variants. In the absence of prevention agents (other than vaccines) and because the prevention of COVID-19 is shifting to a more personalized, patient-specific approach, the complexity of clinical decision-making has...2023-07-0157 minPeerView Infectious Diseases CME/CNE/CPE Audio PodcastShmuel Shoham, MD / Ghady Haidar, MD - What’s New, and What’s Next? Customizing COVID-19 Prevention Approaches in Transplant Patients to Increase Uptake, Access, and EfficacyGo online to PeerView.com/ERY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hundreds of thousands of organ transplant recipients living in the United States, who must take immunosuppressive medication, are at an increased risk of COVID-19 infection. Tixagevimab co-packaged with cilgavimab has lost its emergency use authorization as prevention for immunocompromised patients because of its lack of efficacy against newer variants. In the absence of prevention agents (other than vaccines) and because the prevention of COVID-19 is shifting to a more personalized, patient-specific approach, the complexity of clinical decision-making has...2023-07-0157 minPeerView Infectious Diseases CME/CNE/CPE Video PodcastShmuel Shoham, MD / Ghady Haidar, MD - What’s New, and What’s Next? Customizing COVID-19 Prevention Approaches in Transplant Patients to Increase Uptake, Access, and EfficacyGo online to PeerView.com/ERY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Hundreds of thousands of organ transplant recipients living in the United States, who must take immunosuppressive medication, are at an increased risk of COVID-19 infection. Tixagevimab co-packaged with cilgavimab has lost its emergency use authorization as prevention for immunocompromised patients because of its lack of efficacy against newer variants. In the absence of prevention agents (other than vaccines) and because the prevention of COVID-19 is shifting to a more personalized, patient-specific approach, the complexity of clinical decision-making has...2023-07-0157 minTransplant ID CastInterview with Dr. Jennifer Cuellar-RodriguezJoin me in a discussion on GATA2 deficiency and interview with Dr. Jennifer Cuellar-Rodriguez, Director, Transplant Infectious Diseases Consult Service at NIH. 2023-04-2645 minTransplant ID CastInterview with Ricardo La Hoz on the Topic of Donor Derived InfectionsIn this episode I am joined by Ricardo La Hoz, Director of the Transplant ID Program at UT Southwestern. We are discussing his journey to his current position and his experience and work with donor derived infections.2023-03-2945 minTransplant ID CastInterview with Andrew Karaba, MD., Ph.D.Today I am joined by Andrew Karaba, MD., Ph.D. for a discussion about herpesviruses, immune responsive to viruses, and approach to a case of an immunocompromised woman with acute meningitis.2023-03-1533 minTransplant ID CastAlaa Atamna InterviewIn this episode I am joined by Dr. Alaa Atmna, senior lecturer at Tel Aviv University and consultant for transplant infectious diseases at Beilinson Hospital in Israel. We are discussing UTI’s, C Difficile in transplant, and more.2023-03-0132 minTransplant ID CastMegan Morales InterviewToday I am joined by Dr. Morales, Medical Director of Transplant ID at Virginia Commonwealth University. We are discussing her path to Transplant ID, how her grandfather played an interesting role in history, and two emerging infection cases.2023-02-1534 minTransplant ID CastSaman Nematollahi on medical education, coccidioidomycosis and cryptic species of AspergillusToday I am joined by Dr. Nematollahi from the University of Arizona. We are covering medical education, coccidioidomycosis and cryptic species of Aspergillus.2023-02-0134 minTransplant ID CastJanet Handal Interview: AdvocacyJanet Handal, founder of Transplant Recipients and Immunocompromised Patient Advocacy Group (TRAIPAG) is joining us today to talk about how the group got started, her experience with COVID and getting treatment, and more.2023-01-1835 minTransplant ID CastCamille Kotton interview, CMV and travel in SOTCamille Kotton, Clinical Director of Transplant and Immunocompromised Host Infectious Diseases at Massachusetts General Hospital is joining us today. We are discussing her background and experience, how she would treat several sample cases, and travel after transplantation. 2023-01-0434 minTransplant ID CastNicolas Barros interview. Chagas, Strongyloides and Peruvian socceToday I am joined by Nicolas Barros, Assistant Professor of Clinical Medicine and Medical Director of Transplant Infectious Disease at Indiana University. We are discussing his background, Chagas, Strongyloides, and Peruvian soccer.2022-12-2138 minTransplant ID CastGhady Haidar InterviewIn this episode, I am talking with Ghady Haidar, Director of Research for the Bone Marrow Transplant and Hematological Malignancy Infectious Disease program and Program Director for the Transplant ID Fellowship Program at the University of Pittsburgh, about Transplant ID research, Gram Negative Infections, and much more.2022-12-0734 minTransplant ID CastPeter Chin-Hong; COVID-19, HPV and what it's like to be a dean at UCSFIn this episode, I am joined by Peter Chin-Hong, Professor of Medicine at UCSF and leader of the Immunocompromised Host SEction for Infectious Disease. We are covering how he got started in infectious disease, insight into his publications, treatment options for Covid, and a look at HPV.2022-11-1633 minTransplant ID CastBacteriophages and Saima Aslam interviewIn this episode, I am joined by Dr. Saima Aslam, Professor of Medicine in the Division of Infectious Disease and director of the Transplant Infectious Disease Program at UC San Diego. She is sharing her journey to becoming a physician in San Diego, her many contributions to the field, and information about Phage and her work in this area.2022-10-2631 minTransplant ID CastWilliam Muller Interview, Peds ID, norovirusToday I am talking with Dr. William Muller. Dr. Muller is a pediatric infectious disease physician that focuses on highly immunocompromised kids.
He is sharing his background and journey to pediatric ID, a look inside pediatric infectious disease and Norovirus, and his work with Covid.2022-10-1232 minTransplant ID CastHIV to HIV heart transplant, methenamine and much more.In this episode, I am joined by two Associate Professors of Medicine and Albert Einstein College of Medicine who are sharing their experiences, knowledge, and contributions to the field.
We are covering what TransplantID.net is, their role in the first ever HIV positive to HIV positive heart transplant, the use of Gallium scans, and their study on Methenamine use.
Twitter: @TransplantIDNet
TransplantID.net2022-09-2131 minTransplant ID CastWilla Cochran Interview: Execution of Transplant ID Care from CMV to HIV to COVID-19Willa Cochran, Nurse Practitioner with the Transplant Infectious Disease team and Johns Hopkins, is joining us today to share about her experiences.
We are discussing her journey to becoming a nurse practitioner, her experiences as a nurse practitioner at Johns Hopkins, transplant ID care for patients with HIV, and treatment options for a fictitious case of a 54 year old woman who underwent a kidney transplant and now has Covid-19. 2022-09-0733 minTransplant ID CastMike Ison interview and approach to non-COVID respiratory viral infectionsToday, we are joined by Mike Ison, Professor of Medicine at Northwestern University and Editor-in-Chief of the Transplant Infectious Disease journal.
We are discussing approaches to non-Covid respiratory viral infections and looking at treatment options for a fictitious case of a 34 year old female with Acute Myelogenous Leukemia for which she received a non Myeloablative Haploidentical stem cell transplant.2022-08-1738 minTransplant ID CastImmunosuppression and infection: Dan Brennan InterviewIn this episode, I am joined by Dan Brennan, Professor of Medicine at Johns Hopkins School of Medicine and Director of the Comprehensive Transplant Center at Johns Hopkins. He shares his experiences and the contributions he has made in his career.
We are looking at a case and treatment options of a 52 year old man with a history of diabetes, hypertension, end stage kidney disease and kidney transplant roughly a month ago. He has CMV donor positive, recipient negative status. 2022-08-0337 minPeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastShmuel Shoham, MD - Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your KnowledgeGo online to PeerView.com/EWZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Solid organ transplant recipients may be at increased risk for COVID-19 because they are immunosuppressed and less likely to mount effective immune responses to vaccination. In this educational symposium based on a live event, a panel of expert faculty address the identification of transplant patients who would likely derive benefit from anti-SARS-CoV-2 monoclonal antibodies (mAbs) and strategies that can be used to overcome barriers to COVID-19 pre-exposure prophylaxis access. In addition, they provide guidance on mAb qualities and...2022-07-2248 minPeerView Internal Medicine CME/CNE/CPE Audio PodcastShmuel Shoham, MD - Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your KnowledgeGo online to PeerView.com/EWZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Solid organ transplant recipients may be at increased risk for COVID-19 because they are immunosuppressed and less likely to mount effective immune responses to vaccination. In this educational symposium based on a live event, a panel of expert faculty address the identification of transplant patients who would likely derive benefit from anti-SARS-CoV-2 monoclonal antibodies (mAbs) and strategies that can be used to overcome barriers to COVID-19 pre-exposure prophylaxis access. In addition, they provide guidance on mAb qualities and...2022-07-2248 minPeerView Internal Medicine CME/CNE/CPE Video PodcastShmuel Shoham, MD - Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your KnowledgeGo online to PeerView.com/EWZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Solid organ transplant recipients may be at increased risk for COVID-19 because they are immunosuppressed and less likely to mount effective immune responses to vaccination. In this educational symposium based on a live event, a panel of expert faculty address the identification of transplant patients who would likely derive benefit from anti-SARS-CoV-2 monoclonal antibodies (mAbs) and strategies that can be used to overcome barriers to COVID-19 pre-exposure prophylaxis access. In addition, they provide guidance on mAb qualities and...2022-07-2248 minPeerView Immunology & Transplantation CME/CNE/CPE Audio PodcastShmuel Shoham, MD - Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your KnowledgeGo online to PeerView.com/EWZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Solid organ transplant recipients may be at increased risk for COVID-19 because they are immunosuppressed and less likely to mount effective immune responses to vaccination. In this educational symposium based on a live event, a panel of expert faculty address the identification of transplant patients who would likely derive benefit from anti-SARS-CoV-2 monoclonal antibodies (mAbs) and strategies that can be used to overcome barriers to COVID-19 pre-exposure prophylaxis access. In addition, they provide guidance on mAb qualities and...2022-07-2248 minPeerView Clinical Pharmacology CME/CNE/CPE VideoShmuel Shoham, MD - Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your KnowledgeGo online to PeerView.com/EWZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Solid organ transplant recipients may be at increased risk for COVID-19 because they are immunosuppressed and less likely to mount effective immune responses to vaccination. In this educational symposium based on a live event, a panel of expert faculty address the identification of transplant patients who would likely derive benefit from anti-SARS-CoV-2 monoclonal antibodies (mAbs) and strategies that can be used to overcome barriers to COVID-19 pre-exposure prophylaxis access. In addition, they provide guidance on mAb qualities and...2022-07-2248 minPeerView Infectious Diseases CME/CNE/CPE Audio PodcastShmuel Shoham, MD - Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your KnowledgeGo online to PeerView.com/EWZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Solid organ transplant recipients may be at increased risk for COVID-19 because they are immunosuppressed and less likely to mount effective immune responses to vaccination. In this educational symposium based on a live event, a panel of expert faculty address the identification of transplant patients who would likely derive benefit from anti-SARS-CoV-2 monoclonal antibodies (mAbs) and strategies that can be used to overcome barriers to COVID-19 pre-exposure prophylaxis access. In addition, they provide guidance on mAb qualities and...2022-07-2248 minPeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastShmuel Shoham, MD - Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your KnowledgeGo online to PeerView.com/EWZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Solid organ transplant recipients may be at increased risk for COVID-19 because they are immunosuppressed and less likely to mount effective immune responses to vaccination. In this educational symposium based on a live event, a panel of expert faculty address the identification of transplant patients who would likely derive benefit from anti-SARS-CoV-2 monoclonal antibodies (mAbs) and strategies that can be used to overcome barriers to COVID-19 pre-exposure prophylaxis access. In addition, they provide guidance on mAb qualities and...2022-07-2248 minPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastShmuel Shoham, MD - Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your KnowledgeGo online to PeerView.com/EWZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Solid organ transplant recipients may be at increased risk for COVID-19 because they are immunosuppressed and less likely to mount effective immune responses to vaccination. In this educational symposium based on a live event, a panel of expert faculty address the identification of transplant patients who would likely derive benefit from anti-SARS-CoV-2 monoclonal antibodies (mAbs) and strategies that can be used to overcome barriers to COVID-19 pre-exposure prophylaxis access. In addition, they provide guidance on mAb qualities and...2022-07-2248 minPeerView Immunology & Transplantation CME/CNE/CPE Video PodcastShmuel Shoham, MD - Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your KnowledgeGo online to PeerView.com/EWZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Solid organ transplant recipients may be at increased risk for COVID-19 because they are immunosuppressed and less likely to mount effective immune responses to vaccination. In this educational symposium based on a live event, a panel of expert faculty address the identification of transplant patients who would likely derive benefit from anti-SARS-CoV-2 monoclonal antibodies (mAbs) and strategies that can be used to overcome barriers to COVID-19 pre-exposure prophylaxis access. In addition, they provide guidance on mAb qualities and...2022-07-2248 minPeerView Infectious Diseases CME/CNE/CPE Video PodcastShmuel Shoham, MD - Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your KnowledgeGo online to PeerView.com/EWZ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Solid organ transplant recipients may be at increased risk for COVID-19 because they are immunosuppressed and less likely to mount effective immune responses to vaccination. In this educational symposium based on a live event, a panel of expert faculty address the identification of transplant patients who would likely derive benefit from anti-SARS-CoV-2 monoclonal antibodies (mAbs) and strategies that can be used to overcome barriers to COVID-19 pre-exposure prophylaxis access. In addition, they provide guidance on mAb qualities and...2022-07-2248 minTransplant ID CastCMV infection in BMT and Bill Werbel InterviewIn this episode, we are looking at a case of a 62 year old many with a history of AML, who underwent a bone marrow transplant, and what his risks are for CMV Viremia and CMV complications.
I am joined by Bill Werbel, Assistant Professor of Medicine in the Division of Infectious Disease working on the Transplant and Oncology Infectious Disease team, to talk about his journey to working in infectious disease and his experiences.2022-07-2046 min
Critical Care ScenariosEpisode 49: Invasive pulmonary aspergillosis with Shmuel ShohamWe discuss invasive aspergillosis, with a focus on when to consider and how to make this difficult diagnosis in the general ICU population—with Dr. Shmuel Shoham (@ShohamTxID), Associate Professor of Medicine at Johns Hopkins, transplant infectious disease physician, and an extensively published expert in invasive fungal infections as well as host of the Transplant ID … Continue reading "Episode 49: Invasive pulmonary aspergillosis with Shmuel Shoham"2022-07-1744 minTransplant ID CastTreatment of acute COVID-19 and Olivia Kates InterviewIn this episode, we are looking at current Covid-19 treatment options for a 47 year old female with diabetes, hypertension, end stage renal disease who had a kidney transplant 2 years ago.
My colleague, Assistant Professor of Medicine in the Division of Infectious Diseases at Johns Hopkins University School of Medicine, Olivia Kates, is joining me to talk about her experience with conducting a Covid-19 study at the beginning of the pandemic and her first years as a physician.2022-07-0642 min
DKBmed Radio11/17/2021 - Variants Impact on COVID-19 TreatmentShmuel Shoham, MD and Willa V. Cochran, MSN, CRNP discuss how variants are impacting COVID-19 treatment decisions. Topics: *Where are the variants of concern in the US? *Projecting future variant spread *Which monoclonal antibodies are effective for particular variants *Facilitating treatment with monoclonal antibodies Credit available: 1.0 of AMA, ANCC, AAPA, or ACPE Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/11-17-21-episode/eval Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty Presenting faculty: Shmuel Sho...2021-11-1946 min
DKBmed RadioUPDATE 4/1/2021 - Frontline Treatments with Q&AIn this on-demand video webinar, Shmuel Shoham, MD and Willa V. Cochran, MSN, CRNP discuss what we should know about monoclonal antibodies and how they can be used to improve COVID-19 patient outcomes. Topics: *What is a monoclonal antibody and what monoclonal antibodies are available? *Accurately identifying patients eligible for monoclonal antibodies *How do viral variants affect these treatments? *A case presentation demonstrating the process of referring a patient to get access to monoclonal antibodies *The latest monoclonal antibody recommendations and clinical data Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/4-1-21-e...2021-04-1641 min
Public Health Out LoudMaking Sense of Convalescent PlasmaScientists across the world sprang into action when it was evident we had a pandemic on our hands. In the race to help prevent hospitalizations and deaths, researchers turned to convalescent plasma as a treatment candidate against COVID-19.While doctors and medical professionals have since turned to other treatments and strategies to curb the spread of COVID-19, many were left wondering, “what happened with convalescent plasma?”In today’s episode, Dr. Shmuel Shoham of Johns Hopkins University joins our hosts to discuss just that. Dr. Shoham is an infectious disease specialist who primarily worked with transp...2021-03-1221 min
Rosner's DomainEphraim Shoham-Steiner: Jews and Crime in Medieval Europe Shmuel Rosner and Ephraim Shoham-Steiner discuss Shoham-Steiner's latest book: Jews and Crime in Medieval Europe. Prof. Ephraim Shoham-Steiner is a historian specializing in Medieval Jewish History. He is an associate professor at the Department of Jewish History at Ben-Gurion University of the Negev in Be'er-Shevah. He is also the director of The Center for the Study of Conversion and Inter-Religious Encounters at BGU. Follow Shmuel Rosner on Twitter. 2021-01-0533 min
Health Professional Radio - PodcastCOVID-19 Convalescent Blood Plasma Trials UnderwayDr. Shmuel Shoham, Associate Professor of Medicine at Johns Hopkins University School of Medicine discusses the multi-center, double-blind randomized controlled convalescent blood plasma trials that are currently testing to determine whether giving people antibodies is effective attreating early-stage coronavirus and in preventing those exposed to it from catching the disease. He explains how this research differs from other therapeutics and vaccines under development and why researchers believe it may be promising for COVID-19. He talks about which patients are good candidates for these trials, and what patients can expect if they choose to participate.2020-10-2711 min
RZ חדשיThe Role of a Local Rabbis in Israel with Rabbi David StavFollowing last week's discussion about Rav Shmuel Eliyahu, we wanted to know more about the challenges inherent in servicing as an official rabbi in the State of Israel. We are fortunate that Rabbi David Stav, Chief Rabbi of Shoham, agreed to join us to speak about his experiences. In a wide-ranging discussion, Rav Stav explained the official responsibilities of a local rabbi in Israel today, who employs him, what he does (or does not) do every day, and how his work can influence the Israeli public in a myriad of ways.2020-10-1548 min
DKBmed RadioUPDATE 7/31/2020 – COVID-19: Keeping Up With A Moving TargetDr. Auwaerter interviews Dr. Shmuel Shoham about clinical trial challenges in the era of COVID-19. Topics: *Regulatory, cultural and social challenges *Patient recruitment *Convalescent plasma *Multiple competing studies for inpatients *Problems with COVID+ space for outpatient research The post UPDATE 7/31/2020 – COVID-19: Keeping Up With A Moving Target appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2020-07-3017 minDKBmed RadioUPDATE 7/29/2020 – COVID-19: Keeping Up With A Moving TargetDr. Auwaerter interviews Dr. Shmuel Shoham about COVID-19 prophylaxis trials. Topics: *Hydroxychloroquine *Monoclonal antibodies *Convalescent plasma *Vaccine trials *Challenges of these trialsThe post UPDATE 7/29/2020 – COVID-19: Keeping Up With A Moving Target appeared first on DKBmed Radio. Hosted on Acast. See acast.com/privacy for more information.2020-07-2917 min
Let's Talk IDCOVID-19: Convalescent Plasma (June 30, 2020)We're joined by Drs. Liise-Anne Pirofski of Albert Einstein College of Medicine & Shmuel Shoham of Johns Hopkins University to examine convalescent plasma and its role in the treatment of COVID-19.2020-06-3035 min
Rosner's DomainHizky Shoham: Israel celebratesShmuel Rosner and Hizky Shoham discuss Hizky's newest book and the differences and similarities of how Israel celebrates Passover and its independence day. Hizky Shoham is a cultural historian of Israel and Zionism. He is a research fellow in the Shalom Hartman Institute in Jerusalem and a lecturer in the Interdisciplinary Program for Hermeneutics and Cultural Studies at Bar-Ilan University, Israel. Follow Shmuel Rosner on Twitter. 2020-04-2136 minTransplant ID CastMasks, COVID-19 and Christine Durand Interview2020-03-0520 minTransplant ID CastCameron Wolfe Interview COVID-19Interview with Cameron Wolfe providing update on COVID-19 in Transplant2020-03-0425 minTransplant ID CastCOVID-19 and transplantBackground on novel coronavirus and review of guidance from professional societies and health authorities on this infection in transplant patients2020-02-2613 minTransplant ID CastEpisode 2: Donor with flu, norovirus issues, Robin Avery interview and penguins!2020-02-2142 min
Transplant ID CastEpisode 1First (hopefully of many) Transplant ID podcast. Patient case, listener questions and a bit of music. 2020-02-1635 min